The final, formatted version of the article will be published soon.
CASE REPORT article
Front. Med.
Sec. Nephrology
Volume 11 - 2024 |
doi: 10.3389/fmed.2024.1511493
Diverse clinical manifestations and prognosis in a couple's mercury poisoning caused by skin-lightening creams: two case reports and literature review
Provisionally accepted- Nanjing Center for Disease Control and Prevention, Nanjing, China
Skin exposure to mercury-containing creams occurs most commonly in young and middle-aged women and, in a few cases, in men. This article presents the symptoms and prognosis of a couple who developed mercury poisoning after cosmetic use of similar duration and dosage. Case 1 is a 33-year-old man who developed nephrotic syndrome after using skin-lightening creams containing mercury over nine months. Renal puncture pathology indicated membranous nephropathy. During the course of the illness, the patient intermittently took Chinese medicine. Approximately four months later, the patient developed pulmonary thrombosis and lower extremity venous thrombosis as a result of fatigue driving and had to undergo thrombolysis and filter implantation. A urine mercury level of 65.4 μg/g•creatinine was detected in the patient. The urine protein level remained positive eight months after mercury removal. Case 2 is a 30-year-old woman, the wife of case 1, who used the same creams for 9 months with her husband and had a urine mercury level of 80μg/g•creatinine. The patient experienced sleep disturbances, fatigue, and irritability. In Case 2, neurasthenia symptoms were relieved following mercury removal, and no other complications were observed. There have been very few reports regarding male patients developing nephrotic syndrome as a consequence of using cosmetics that contain mercury. However, clinicians should not neglect this cause when dealing with newly diagnosed male patients with nephrotic syndrome. The treatment and prognosis of male patients are less well established, and changes in their condition must be closely monitored.
Keywords: Mercury Poisoning, Nephrotic Syndrome, mercury removal therapy, prognosis, case report
Received: 15 Oct 2024; Accepted: 27 Dec 2024.
Copyright: © 2024 Ji, Chen, Liu, zhou and Tang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Ye Chen, Nanjing Center for Disease Control and Prevention, Nanjing, China
Dandan Liu, Nanjing Center for Disease Control and Prevention, Nanjing, China
Tongzhou zhou, Nanjing Center for Disease Control and Prevention, Nanjing, China
Yuhua Tang, Nanjing Center for Disease Control and Prevention, Nanjing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.